Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity
PHASE4CompletedINTERVENTIONAL
Enrollment
65
Participants
Timeline
Start Date
June 30, 2005
Primary Completion Date
March 31, 2006
Study Completion Date
March 31, 2006
Conditions
Obesity
Interventions
DRUG
Metformin
Metformin is used.
Trial Locations (1)
9000
University Hospital Ghent, Ghent
All Listed Sponsors
collaborator
Merck Sharp & Dohme LLC
INDUSTRY
lead
University Hospital, Ghent
OTHER
NCT00134303 - Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity | Biotech Hunter | Biotech Hunter